Mostly based on the analogy between ErbB2 knockout-induced cardiomyopathy and trastuzumab-induced heart failure, many studies have concluded that trastuzumab causes heart failure by blocking the physiological actions of ErbB2 in the heart [32, 33]. This evidence concerns the gene ERBB2 and cardiomyopathy.